INDV
#1365
Indivior Pharmaceuticals, Inc. - Common Stock
41.3 3 USD
+0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.73%
Variación mensual
+7.02%
Variación en los últimos 6 meses
+23.01%
Cambio anual
+23.01%
Cierres anteriores
40.2 3
Open
40.5 8
Mínimo
40.5 2
High
41.5 2
Volumen
662
Financials
- Market Capitalization 5.04 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
21.88
Relación precio/flujo de caja
3.71
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1143 |  LNTH Lantheus Holdings, Inc. - Common Stock | 104.85 USD | +2.42% | -0.12% | -0.14% | +87.03% | 6.83 B USD | ||
| 1288 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.10 USD | +2.46% | +3.51% | +4.91% | +62.09% | 5.46 B USD | ||
| 1803 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.00 USD | +0.73% | -1.76% | +6.60% | -12.96% | 2.73 B USD | ||
| 1836 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.20 USD | -7.96% | -30.48% | -69.36% | -64.14% | 2.57 B USD |